top of page

REIMAGINING CANCER TREATMENT MANAGEMENT

High-affinity tests that monitor the use of onco-therapeutics that support cancer treatment de-escalation to achieve better outcomes with less drug, less cost and improved quality of life.

Martell commercializes tests that measure blood-borne tumor biomarkers, an adjunct to cancer care.  Our tests monitor the efficacy of targeted, disease-specific drugs.

OUR TESTS

HERTEST®

A Breast Cancer Blood Test

HERTEST® rises with tumor progression and falls when treatment is effective.

CHECKMARK®

A Serum Test to Measure Soluble PD-L1

CHECKMARK® is elevated in patients with several cancer types.

bottom of page